Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals (TERN) Financial Statements


Terns Pharmaceuticals Financial Overview

Terns Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.264; its P/E ratio is -5.78; Terns Pharmaceuticals is scheduled to report earnings on March 26, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -29.71M$ -17.82M$ -21.47M$ -15.50M$ -17.29M
EBITDA$ -31.24M$ -18.58M$ -22.05M$ -15.84M$ -17.04M
Net Income Common Stockholders$ -29.77M$ -17.90M$ -21.53M$ -15.82M$ -16.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 266.60M$ 285.60M$ 297.53M$ 283.11M$ 187.29M
Total Assets$ 271.69M$ 289.70M$ 300.60M$ 287.03M$ 192.59M
Total Debt$ 770.00K$ 876.00K$ 1.04M$ 1.21M$ 1.37M
Net Debt$ -265.83M$ -284.73M$ -296.48M$ -281.91M$ -185.92M
Total Liabilities$ 13.26M$ 15.55M$ 13.60M$ 10.08M$ 8.89M
Stockholders Equity$ 258.43M$ 274.15M$ 287.68M$ 276.94M$ 183.69M
Cash Flow-
Free Cash Flow$ -20.71M$ -12.99M$ -14.38M$ -11.24M$ -13.43M
Operating Cash Flow$ -20.70M$ -12.99M$ -14.38M$ -11.21M$ -13.44M
Investing Cash Flow$ -22.31M$ -90.84M$ 27.93M$ -14.55M$ -1.24M
Financing Cash Flow$ 20.00K$ 489.00K$ 27.58M$ 105.97M$ 61.00M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

Terns Pharmaceuticals Debt to Assets

Terns Pharmaceuticals Cash Flow

Terns Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis